Theravance Biopharma (TBPH) Work In Process (2013 - 2018)

Theravance Biopharma (TBPH) has reported Work In Process for 5 consecutive years, with $3.6 million the latest figure, recorded in Q3 2018.

• In Q3 2018, Work In Process rose 379.89% year-over-year to $3.6 million; the TTM figure through Sep 2018 stood at $3.6 million (up 379.89% YoY), while the FY2017 annual figure was $66000.0, down 97.49% from the prior year.
• Work In Process rose to $3.6 million in Q3 2018 per TBPH's latest filing, from $3.3 million in the prior quarter.
• Across five years, Work In Process topped out at $3.6 million in Q3 2018 and bottomed at $66000.0 in Q4 2017.
• Historically, Work In Process has averaged $1.9 million across 4 years, with a median of $2.0 million in 2018.
• Annual changes were most pronounced in 2017 — Work In Process plunged 97.49% — and 2018, when it surged 379.89%.
• Theravance Biopharma's Work In Process stood at $145000.0 in 2014, then surged by 1711.72% to $2.6 million in 2016, then slumped by 97.49% to $66000.0 in 2017, then surged by 5396.97% to $3.6 million in 2018.
• Business Quant data shows TBPH's Work In Process at $3.6 million in Q3 2018, $3.3 million in Q2 2018, and $2.0 million in Q1 2018.